1. Home
  2. VYGR vs AIRS Comparison

VYGR vs AIRS Comparison

Compare VYGR & AIRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Voyager Therapeutics Inc.

VYGR

Voyager Therapeutics Inc.

HOLD

Current Price

$3.79

Market Cap

194.0M

Sector

Health Care

ML Signal

HOLD

AIRS

AirSculpt Technologies Inc.

HOLD

Current Price

$1.73

Market Cap

166.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VYGR
AIRS
Founded
2013
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Medical/Nursing Services
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
194.0M
166.3M
IPO Year
2015
2021

Fundamental Metrics

Financial Performance
Metric
VYGR
AIRS
Price
$3.79
$1.73
Analyst Decision
Strong Buy
Hold
Analyst Count
6
1
Target Price
$17.00
$2.50
AVG Volume (30 Days)
527.4K
859.1K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$10,135,000.00
$180,350,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$71.77
$2.55
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.65
$1.53
52 Week High
$5.55
$12.00

Technical Indicators

Market Signals
Indicator
VYGR
AIRS
Relative Strength Index (RSI) 47.48 33.72
Support Level $2.79 N/A
Resistance Level $3.73 $3.29
Average True Range (ATR) 0.21 0.21
MACD 0.00 -0.04
Stochastic Oscillator 54.65 8.93

Price Performance

Historical Comparison
VYGR
AIRS

About VYGR Voyager Therapeutics Inc.

Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.

About AIRS AirSculpt Technologies Inc.

AirSculpt Technologies Inc is a national provider of body contouring procedures delivering a premium consumer experience under its brand Elite Body Sculpture. Elite Body Sculpture, provides custom body contouring using the proprietary AirSculpt method that removes unwanted fat in a minimally invasive procedure. The company has one operating and reportable segment, direct medical procedure services.

Share on Social Networks: